Skip to content
Psych Dictionary

Placebo effect (psychology)

  • Concept · Psychology, medicine and psychotherapy research
  • Mixed or contested
  • Published October 20, 2026
  • 15 sources
  • 5 min read

In short

The placebo effect is improvement attributable to the context of a treatment, such as the expectation of benefit, rather than to its specific ingredients. Its negative counterpart is the nocebo effect. In psychotherapy research, where no inert treatment exists, what counts as a placebo control is itself disputed.

Key facts

Field
Psychology, medicine and psychotherapy research
Also known as
Placebo response; Nocebo effect; Psychological placebo

State of the evidence

Mixed or contested

Experiments show that verbal suggestion and conditioning can produce placebo and nocebo responses[1][2]. In trials that randomized patients to placebo or no treatment, placebos had no important clinical effects in general but could influence patient-reported outcomes such as pain and nausea[3]. Open-label placebos showed a significant pooled effect across 11 small trials[4]. In psychotherapy, whether well-designed placebo controls are as effective as established treatments is disputed[5][6][7].

Evidence labels summarise the research literature; they are not recommendations. How labels are assigned

The placebo effect is the improvement in a person’s condition that is attributable to the context in which a treatment is given, such as the expectation of benefit and the interaction with the clinician, rather than to the treatment’s specific ingredients. Placebos were long defined by their inert content and their use as controls in trials. More recent research treats placebo effects as genuine psychobiological events produced by the overall therapeutic context, which can occur in clinical practice even when no placebo is given[8]. The nocebo effect is the negative counterpart: worse outcomes, such as adverse effects, produced by negative expectations arising from the clinical encounter[9].

Placebo and nocebo effects pose a specific problem for trials of psychological treatment.

Change in a placebo group and the placebo effect

Improvement in a placebo group is not the same thing as the placebo effect. Change from baseline in any arm of a trial combines spontaneous improvement with placebo effects and, in the active arm, the effect of treatment, and estimating the separate contributions requires a no-treatment arm[10]. Part of the apparent improvement can also be regression to the mean, the statistical tendency for unusually high or low measurements to be followed by values closer to the average[11].

A meta-analysis of 37 trials that randomized patients to no treatment, placebo or an active intervention did exactly that. All three arms changed significantly from baseline: by a standardized mean difference of 0.24 with no treatment, 0.44 with placebo and 1.01 with active treatment. Spontaneous improvement and placebo each accounted for a substantial share of the change seen with active treatment, about 24% and 20% on average, with the most pronounced spontaneous improvement in nausea, smoking, depression, phobia and acute pain[10]. Seventeen of the active interventions were psychological[10].

Expectancy and conditioning accounts

Two theories have competed to explain placebo effects: expectancy theory and classical conditioning[2]. Stewart-Williams and Podd argued that the debate dissolves once two questions are separated: what shapes placebo effects, and what learning mediates them. Conditioning procedures and verbal information can both shape placebo effects; sometimes they do so by changing conscious expectancies, and sometimes conditioning produces placebo effects that are not mediated by conscious cognition[2].

Experiments support that division. In one series, verbal suggestions of more or less pain, or of better or worse motor performance in people with Parkinson’s disease, completely overrode the effect of a prior conditioning procedure. Verbal suggestions had no effect on hormone secretion, which changed only after pharmacological preconditioning. The authors concluded that conscious processes such as pain are mediated by expectation, and unconscious physiological functions by conditioning[1]. Kirsch, defending the expectancy account, argued that conditioning can produce or enhance placebo effects but that these are generally mediated by expectancy, which can also produce effects that are inconsistent with a person’s conditioning history[7].

How large placebo effects are

Estimates depend on the comparison. A Cochrane review of 234 trials that randomized patients to placebo or no treatment did not find important clinical effects of placebo in general. Placebos could influence patient-reported outcomes, especially pain and nausea, although such effects are hard to distinguish from biased reporting, and the effect on pain ranged from negligible to clinically important even among trials at low risk of bias. Larger effects were associated with physical placebos such as sham acupuncture, patient-involved outcomes, small trials and trials designed to study placebo[3].

Wampold and colleagues reanalyzed an earlier version of that review and reached a different conclusion: when a disorder is amenable to placebo and the design can detect the effect, the placebo effect is robust and approaches the treatment effect[6].

Nocebo effects

Negative expectations produce negative outcomes. Research on the nocebo effect indicates that disclosing possible side effects can itself contribute to producing them, that the content and presentation of information in both placebo and active arms of trials influence nocebo responses, and that the informed consent process may induce them[9]. A systematic review of 89 studies in which people were exposed to an inert substance found that the strongest predictors of nocebo symptoms were a higher perceived dose, explicit suggestions that the exposure causes symptoms, observing other people experiencing symptoms and higher expectations of symptoms[12].

Open-label placebos

An open-label placebo is given without deception: the person is told that it is a placebo. A meta-analysis of 11 randomized trials comparing open-label placebos with no treatment, in conditions including back pain, cancer-related fatigue, irritable bowel syndrome, allergic rhinitis and major depression, found a significant overall effect (standardized mean difference 0.72) with high heterogeneity and moderate risk of bias. The authors described the research as in its infancy and called for work on the instructions given with the placebo and on the role of expectations[4].

Placebo controls in psychotherapy research

Psychotherapy has no inert equivalent of a sugar pill. Double-blinding, the standard in drug trials, cannot be applied to most psychological treatments, and elements that are nonspecific in drug therapy, such as the frequency and intensity of contact with the therapist, are specific ingredients in psychotherapy[13]. Trials therefore use a range of control conditions, including waiting lists, no treatment and “psychological placebos”[14], and the results of a trial can depend as much on the choice of control condition as on the treatment tested[15].

The choice changes the answer. In a network meta-analysis of 49 trials of cognitive behavioral therapy for depression, effect estimates differed substantially depending on whether the comparison was a waiting list, no treatment or a psychological placebo; patients on a waiting list fared worse than those receiving no treatment at all, which led the authors to suggest that a waiting list may act as a nocebo condition, although the difference did not survive adjustment for publication bias[14].

Whether a psychological placebo is a fair control is the subject of a long dispute. A meta-analysis found that active treatments outperformed placebos that were structurally unlike them, in session number and length, therapist training, format or permitted topics, but showed negligible advantages over structurally equivalent placebos[5]. Wampold and colleagues concluded that properly designed psychological placebos are as effective as accepted psychotherapies[6]. Kirsch argued that expectancy matters in psychotherapy outcome but that the logic of placebo-controlled trials does not map onto psychotherapy, and that trying to control for nonspecific or placebo factors rests on a flawed analogy and should be abandoned[7]. Enck and Zipfel disagreed, proposing instead a framework that separates context factors, common factors and specific factors, and new trial designs to control placebo effects in psychotherapy[13]. The broader dispute is covered under common factors.

Sources15

Numbered in order of first citation.

  1. 1.Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003). Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. The Journal of Neuroscience, 23(10), 4315–4323. https://doi.org/10.1523/JNEUROSCI.23-10-04315.2003
  2. 2.Stewart-Williams, S., & Podd, J. (2004). The placebo effect: Dissolving the expectancy versus conditioning debate. Psychological Bulletin, 130(2), 324–340. https://doi.org/10.1037/0033-2909.130.2.324
  3. 3.Hróbjartsson, A., & Gøtzsche, P. C. (2010). Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews, 2010(1), CD003974. https://doi.org/10.1002/14651858.CD003974.pub3
  4. 4.von Wernsdorff, M., Loef, M., Tuschen-Caffier, B., & Schmidt, S. (2021). Effects of open-label placebos in clinical trials: A systematic review and meta-analysis. Scientific Reports, 11(1), 3855. https://doi.org/10.1038/s41598-021-83148-6
  5. 5.Baskin, T. W., Tierney, S. C., Minami, T., & Wampold, B. E. (2003). Establishing specificity in psychotherapy: A meta-analysis of structural equivalence of placebo controls. Journal of Consulting and Clinical Psychology, 71(6), 973–979. https://doi.org/10.1037/0022-006X.71.6.973
  6. 6.Wampold, B. E., Minami, T., Tierney, S. C., Baskin, T. W., & Bhati, K. S. (2005). The placebo is powerful: Estimating placebo effects in medicine and psychotherapy from randomized clinical trials. Journal of Clinical Psychology, 61(7), 835–854. https://doi.org/10.1002/jclp.20129
  7. 7.Kirsch, I. (2005). Placebo psychotherapy: Synonym or oxymoron?. Journal of Clinical Psychology, 61(7), 791–803. https://doi.org/10.1002/jclp.20126
  8. 8.Finniss, D. G., Kaptchuk, T. J., Miller, F., & Benedetti, F. (2010). Biological, clinical, and ethical advances of placebo effects. The Lancet, 375(9715), 686–695. https://doi.org/10.1016/S0140-6736(09)61706-2
  9. 9.Colloca, L., & Miller, F. G. (2011). The nocebo effect and its relevance for clinical practice. Psychosomatic Medicine, 73(7), 598–603. https://doi.org/10.1097/PSY.0b013e3182294a50
  10. 10.Krogsbøll, L. T., Hróbjartsson, A., & Gøtzsche, P. C. (2009). Spontaneous improvement in randomised clinical trials: Meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Medical Research Methodology, 9(1), 1. https://doi.org/10.1186/1471-2288-9-1
  11. 11.Barnett, A. G., van der Pols, J. C., & Dobson, A. J. (2005). Regression to the mean: What it is and how to deal with it. International Journal of Epidemiology, 34(1), 215–220. https://doi.org/10.1093/ije/dyh299
  12. 12.Webster, R. K., Weinman, J., & Rubin, G. J. (2016). A systematic review of factors that contribute to nocebo effects. Health Psychology, 35(12), 1334–1355. https://doi.org/10.1037/hea0000416
  13. 13.Enck, P., & Zipfel, S. (2019). Placebo effects in psychotherapy: A framework. Frontiers in Psychiatry, 10, 456. https://doi.org/10.3389/fpsyt.2019.00456
  14. 14.Furukawa, T. A., Noma, H., Caldwell, D. M., Honyashiki, M., Shinohara, K., Imai, H., Chen, P., Hunot, V., & Churchill, R. (2014). Waiting list may be a nocebo condition in psychotherapy trials: A contribution from network meta‐analysis. Acta Psychiatrica Scandinavica, 130(3), 181–192. https://doi.org/10.1111/acps.12275
  15. 15.Mohr, D. C., Spring, B., Freedland, K. E., Beckner, V., Arean, P., Hollon, S. D., Ockene, J., & Kaplan, R. (2009). The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychotherapy and Psychosomatics, 78(5), 275–284. https://doi.org/10.1159/000228248

Further reading

Cite this entry

  • APA 7

    Psych Dictionary. (2026, October 20). Placebo effect (psychology). In Psych Dictionary. https://www.psychdictionary.com/concepts/placebo-effect

  • MLA 9

    “Placebo Effect (psychology).” Psych Dictionary, 20 Oct. 2026, www.psychdictionary.com/concepts/placebo-effect.

Written by Editorial team. First published October 20, 2026. Editorial standards

Educational reference material. Nothing on this site is a diagnosis, a treatment recommendation or a substitute for care from a qualified clinician.